BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10905566)

  • 1. Elevated antibody levels to Epstein-Bbarr virus antigens in patients with hairy cell leukemia compared to controls in relation to exposure to pesticides, organic solvents, animals, and exhausts.
    Nordström M; Hardell L; Linde A; Schloss L; Näsman A
    Oncol Res; 1999; 11(11-12):539-44. PubMed ID: 10905566
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipose tissue concentrations of dioxins and dibenzofurans, titers of antibodies to Epstein-Barr virus early antigen and the risk for non-Hodgkin lymphoma.
    Hardell L; Lindström G; van Bavel B; Hardell K; Linde A; Carlberg M; Liljegren G
    Environ Res; 2001 Oct; 87(2):99-107. PubMed ID: 11683593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-barr virus-associated non-Hodgkin's lymphoma of B-cell origin, Hodgkin's disease, acute leukemia, and systemic lupus erythematosus: a serologic and molecular analysis.
    Mitarnun W; Pradutkanchana J; Takao S; Saechan V; Suwiwat S; Ishida T
    J Med Assoc Thai; 2002 May; 85(5):552-9. PubMed ID: 12188384
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concentrations of organochlorines related to titers to Epstein-Barr virus early antigen IgG as risk factors for hairy cell leukemia.
    Nordström M; Hardell L; Lindström G; Wingfors H; Hardell K; Linde A
    Environ Health Perspect; 2000 May; 108(5):441-5. PubMed ID: 10811571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seroepidemiological study of relationships between Epstein-Barr virus and rheumatoid arthritis.
    Ferrell PB; Aitcheson CT; Pearson GR; Tan EM
    J Clin Invest; 1981 Mar; 67(3):681-7. PubMed ID: 6259207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High prevalence of immunoglobulin A antibody against Epstein-Barr virus capsid antigen in adult patients with lupus with disease flare: case control studies.
    Chen CJ; Lin KH; Lin SC; Tsai WC; Yen JH; Chang SJ; Lu SN; Liu HW
    J Rheumatol; 2005 Jan; 32(1):44-7. PubMed ID: 15630723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of plasma Epstein-Barr virus (EBV) DNA levels and serum EBV immunoglobulin A/virus capsid antigen antibody titers in patients with nasopharyngeal carcinoma.
    Shao JY; Li YH; Gao HY; Wu QL; Cui NJ; Zhang L; Cheng G; Hu LF; Ernberg I; Zeng YX
    Cancer; 2004 Mar; 100(6):1162-70. PubMed ID: 15022282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epstein-Barr virus antibodies in patients with laryngeal and hypopharyngeal cancer.
    Morshed K; Polz-Dacewicz M; Szymański M; Rajtar B; Ziaja-Sołtys M; Gołabek W
    Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):227-31. PubMed ID: 15323196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus and risk of non-Hodgkin lymphoma in the cancer prevention study-II and a meta-analysis of serologic studies.
    Teras LR; Rollison DE; Pawlita M; Michel A; Brozy J; de Sanjose S; Blase JL; Gapstur SM
    Int J Cancer; 2015 Jan; 136(1):108-16. PubMed ID: 24831943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.
    Chang KP; Hsu CL; Chang YL; Tsang NM; Chen CK; Lee TJ; Tsao KC; Huang CG; Chang YS; Yu JS; Hao SP
    Oral Oncol; 2008 Aug; 44(8):784-92. PubMed ID: 18206420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus and human immunodeficiency virus serological responses and viral burdens in HIV-infected patients treated with HAART.
    O'Sullivan CE; Peng R; Cole KS; Montelaro RC; Sturgeon T; Jenson HB; Ling PD
    J Med Virol; 2002 Jul; 67(3):320-6. PubMed ID: 12116021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Native early antigen of Epstein-Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma.
    Paramita DK; Fachiroh J; Artama WT; van Benthem E; Haryana SM; Middeldorp JM
    J Med Virol; 2007 Nov; 79(11):1710-21. PubMed ID: 17854043
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased anti-Epstein-Barr virus antibodies in epidermotropic cutaneous T-cell lymphoma: a study of 64 patients.
    Jumbou O; Mollat C; N'Guyen JM; Billaudel S; Litoux P; Dréno B
    Br J Dermatol; 1997 Feb; 136(2):212-6. PubMed ID: 9068734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heterogeneity of risk factors and antibody profiles in epstein-barr virus genome-positive and -negative hodgkin lymphoma.
    Chang ET; Zheng T; Lennette ET; Weir EG; Borowitz M; Mann RB; Spiegelman D; Mueller NE
    J Infect Dis; 2004 Jun; 189(12):2271-81. PubMed ID: 15181575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of maternal Epstein-Barr virus infection and risk of acute leukemia in the offspring.
    Tedeschi R; Bloigu A; Ogmundsdottir HM; Marus A; Dillner J; dePaoli P; Gudnadottir M; Koskela P; Pukkala E; Lehtinen T; Lehtinen M
    Am J Epidemiol; 2007 Jan; 165(2):134-7. PubMed ID: 17005627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene-environment interactions between HLA B7/A2, EBV antibodies are associated with MRI injury in multiple sclerosis.
    Zivadinov R; Weinstock-Guttman B; Zorzon M; Uxa L; Serafin M; Bosco A; Bratina A; Maggiore C; Grop A; Tommasi MA; Srinivasaraghavan B; Ramanathan M
    J Neuroimmunol; 2009 Apr; 209(1-2):123-30. PubMed ID: 19232441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to Epstein-Barr virus-specific antigens in patients with hairy-cell leukemia.
    Sakamoto K; Aiba M; Katayama I; Sullivan JL; Humphreys RE; Purtilo DT
    Int J Cancer; 1981; 27(4):453-8. PubMed ID: 6268553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strong correlations of anti-viral capsid antigen antibody levels in first-degree relatives from families with Epstein-Barr virus-related lymphomas.
    Besson C; Amiel C; Le-Pendeven C; Plancoulaine S; Bonnardel C; Ranque B; Abbed K; Brice P; Fermé C; Carde P; Hermine O; Raphael M; Bresson JL; Nicolas JC; Gessain A; Dethe G; Abel L
    J Infect Dis; 2009 Apr; 199(8):1121-7. PubMed ID: 19284285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of evidence of active lytic replication of Epstein-Barr and cytomegaloviruses in patients with systemic lupus erythematosus.
    Lau CS; Yuen KY; Chan KH; Wong RW
    Chin Med J (Engl); 1998 Jul; 111(7):660-5. PubMed ID: 11245059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Variability in Epstein-Barr virus serological markers in adult kidney transplant recipients].
    Lauzurica R; Frías C; Bayés B; Ausina V; Romero R
    Nefrologia; 2005; 25(2):185-90. PubMed ID: 15912656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.